RxDoctor Payments Data

Jonathan Lam, MD

Plastic and Reconstructive Surgery · Bethlehem, PANPI 1598051716

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,242 of the $5,082 with a category attached, or 63.8%. 20 manufacturers reported payments, led by TELA Bio, Inc. at 40.9% of the total. Reporting peaked in 2023 at $2,935 and has fallen 86.2% since, to $405 in 2025.

$5,082in general payments, 2019–2025

Across 124 payments — averaging $40.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$2K
  • AbbVie$759
  • Mentor Worldwide LLC$700
  • Smith+Nephew$583
  • Musculoskeletal Transplant Foundation Inc.$274
  • Lifenet Health$185
  • plus $503 from 14 others

What the payments were for

  • Consulting fees$521%
  • Travel & lodging$1,77235%
  • Food & beverage$3,24264%
  • Entertainment$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,082 in reported general payments places this provider in the 75th percentile of 108 plastic and reconstructive surgery providers in Pennsylvania.

See all plastic and reconstructive surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$86,353
Medicare patients
91
Services billed
294

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl12$160
Oxycodone Hcl11$51

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Bethlehem

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →